<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8577772" created="07/05/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8577772</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">In vivo <term id="T1" lex="anergized_CD4+_T_cell" sem="Cell_cultured">anergized CD4+ <term id="T2" lex="T_cell" sem="Cell_natural">T cells</term></term> express perturbed <term id="A1" sem="Protein_complex">AP-1</term> and <term id="T3" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> <term id="T4" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="A1"/>
<clue><clueLoc>In vivo anergized CD4+ T cells</clueLoc> <clueType>express</clueType> perturbed AP-1 and NF-kappa B transcription factors.</clue>
</event>
<event id="E2">
<type class="Gene_expression"/>
<theme idref="T3"/>
<clue><clueLoc>In vivo anergized CD4+ T cells</clueLoc> <clueType>express</clueType> perturbed AP-1 and NF-kappa B transcription factors.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Anergy is a major mechanism to ensure <term id="T5" lex="antigen-specific_tolerance" sem="Other">antigen-specific tolerance</term> in <term id="T6" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> in the adult.</sentence>
<sentence id="S3">In vivo, anergy has mainly been studied at the cellular level.</sentence>
<sentence id="S4">In this study, we used the <term id="T7" lex="T-cell-activating_superantigen" sem="Protein_molecule"><term id="A21" sem="Cell_natural">T-cell</term>-activating superantigen</term> <term id="T8" lex="staphylococcal_enterotoxin_A" sem="Protein_molecule">staphylococcal enterotoxin A</term> (<term id="T9" lex="SEA" sem="Protein_molecule">SEA</term>) to investigate molecular mechanisms of <term id="T10" lex="T-lymphocyte_anergy" sem="Other">T-lymphocyte anergy</term> in vivo.</sentence>
<event KT="Other" id="E61">
<type class="Physiological_process"/>
<theme idref="A21"/>
<cause idref="T9"/>
<clue>In this study, we used the T-cell-<clueType>activating</clueType> <corefCause>superantigen</corefCause> staphylococcal enterotoxin A (SEA) to investigate molecular mechanisms of T-lymphocyte anergy in vivo.</clue>
</event>
<sentence id="S5">Injection of <term id="T11" lex="SEA" sem="Protein_molecule">SEA</term> to <term id="A22" sem="Multicellular_organism_natural">adult mice</term> activates <term id="A2" sem="Cell_natural"><term id="T12" lex="CD4+_T_cell" sem="Cell_natural">CD4+ <term id="T13" lex="T_cell" sem="Cell_natural">T cells</term></term> expressing certain <term id="T14" lex="T-cell_receptor_(TCR)_variable_region_beta-chain_families" sem="Protein_family_or_group">T-cell receptor (TCR) variable region beta-chain families</term></term> and induces strong and rapid production of interleukin 2 (<term id="T15" lex="IL-2" sem="Protein_molecule">IL-2</term>).</sentence>
<event KT="Method" id="E3">
<type class="Artificial_process"/>
<theme idref="T11"/>
<theme idref="A22"/>
<clue><clueType>Injection</clueType> <linkTheme>of</linkTheme> SEA <linkTheme>to</linkTheme> adult mice activates CD4+ T cells expressing certain T-cell receptor (TCR) variable region beta-chain families and induces strong and rapid production of interleukin 2 (IL-2).</clue>
</event>
<event id="E4">
<type class="Gene_expression"/>
<theme idref="T14"/>
<clue>Injection of SEA to adult mice activates <clueLoc>CD4+ T cells</clueLoc> <clueType>expressing</clueType> certain T-cell receptor (TCR) variable region beta-chain families and induces strong and rapid production of interleukin 2 (IL-2).</clue>
</event>
<event id="E5">
<type class="Physiological_process"/>
<theme idref="A2"/>
<cause idref="E3"/>
<clue>Injection of SEA to adult mice <clueType>activates</clueType> CD4+ T cells expressing certain T-cell receptor (TCR) variable region beta-chain families and induces strong and rapid production of interleukin 2 (IL-2).</clue>
<comment>TPS: A2</comment></event>
<event Manner="High" id="E6">
<type class="Gene_expression"/>
<theme idref="T15"/>
<clue>Injection of SEA to adult mice activates CD4+ T cells expressing certain T-cell receptor (TCR) variable region beta-chain families and induces <clueManner>strong and rapid</clueManner> <clueType>production</clueType> <linkTheme>of</linkTheme> interleukin 2 (IL-2).</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="E3"/>
<clue>Injection of SEA to adult mice activates CD4+ T cells expressing certain T-cell receptor (TCR) variable region beta-chain families and <clueType>induces</clueType> strong and rapid production of interleukin 2 (IL-2).</clue>
</event>
<sentence id="S6">In contrast, repeated injections of <term id="T16" lex="SEA" sem="Protein_molecule">SEA</term> cause <term id="T17" lex="CD4+_T-cell_deletion" sem="Other"><term id="T18" lex="CD4+_T-cell" sem="Cell_natural">CD4+ T-cell</term> deletion</term> and <term id="A3" sem="Other">anergy</term> in the remaining <term id="T19" lex="CD4+_T_cells" sem="Cell_natural">CD4+ T cells</term>, characterized by reduced expression of <term id="T20" lex="IL-2" sem="Protein_molecule">IL-2</term> at <term id="A4" sem="RNA_molecule">mRNA</term> and <term id="A5" sem="Protein_molecule">protein</term> levels.</sentence>
<event KT="Method" id="E8">
<type class="Artificial_process"/>
<theme idref="T16"/>
<clue>In contrast, <clueType>repeated injections</clueType> <linkTheme>of</linkTheme> SEA cause CD4+ T-cell deletion and anergy in the remaining CD4+ T cells, characterized by reduced expression of IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E109">
<type class="Cellular_physiological_process"/>
<theme idref="T18"/>
<clue>In contrast, repeated injections of SEA cause CD4+ T-cell <clueType>deletion</clueType> and anergy in the remaining CD4+ T cells, characterized by reduced expression of IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E110">
<type class="Positive_regulation"/>
<theme idref="E109"/>
<cause idref="E8"/>
<clue>In contrast, repeated injections of SEA <clueType>cause</clueType> CD4+ T-cell deletion and anergy in the remaining CD4+ T cells, characterized by reduced expression of IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<cause idref="E8"/>
<clue>In contrast, repeated injections of SEA <clueType>cause</clueType> CD4+ T-cell deletion and anergy <clueLoc>in the remaining CD4+ T cells</clueLoc>, characterized by reduced expression of IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E11">
<type class="Transcription"/>
<theme idref="T20" idref1="A4"/>
<clue>In contrast, repeated injections of SEA cause CD4+ T-cell deletion and anergy in the remaining CD4+ T cells, characterized by reduced <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2 at mRNA and protein levels.</clue>
<comment>NER: T21 DEL</comment></event>
<event id="E12">
<type class="Gene_expression"/>
<theme idref="T20" idref1="A5"/>
<clue>In contrast, repeated injections of SEA cause CD4+ T-cell deletion and anergy in the remaining CD4+ T cells, characterized by reduced <clueType>expression</clueType> <linkTheme>of</linkTheme> IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E13">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="E8"/>
<clue>In contrast, repeated injections of SEA cause CD4+ T-cell deletion and anergy <clueLoc>in the remaining CD4+ T cells</clueLoc>, characterized by <clueType>reduced</clueType> expression of IL-2 at mRNA and protein levels.</clue>
</event>
<event id="E14">
<type class="Negative_regulation"/>
<theme idref="E12"/>
<cause idref="E8"/>
<clue>In contrast, repeated injections of SEA cause CD4+ T-cell deletion and anergy <clueLoc>in the remaining CD4+ T cells</clueLoc>, characterized by <clueType>reduced</clueType> expression of IL-2 at mRNA and protein levels.</clue>
</event>
<sentence id="S7">We analyzed expression of <term id="T22" lex="AP-1" sem="Protein_molecule">AP-1</term>, <term id="T23" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>, <term id="T24" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term>, and <term id="T25" lex="octamer_binding_transcription_factor" sem="Protein_family_or_group">octamer binding <term id="T26" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term></term>, which are known to be involved in the regulation of <term id="T27" lex="IL-2_gene_promoter_activity" sem="Other"><term id="T28" lex="IL-2" sem="Protein_molecule">IL-2</term> gene promoter activity</term>.</sentence>
<event id="E15" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>We <clueKT>analyzed</clueKT> <clueType>expression</clueType> <linkTheme>of</linkTheme> AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL-2 gene promoter activity.</clue>
</event>
<event id="E16" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T23"/>
<clue>We <clueKT>analyzed</clueKT> <clueType>expression</clueType> <linkTheme>of</linkTheme> AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL-2 gene promoter activity.</clue>
</event>
<event id="E17" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue>We <clueKT>analyzed</clueKT> <clueType>expression</clueType> <linkTheme>of</linkTheme> AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL-2 gene promoter activity.</clue>
</event>
<event id="E18" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>We <clueKT>analyzed</clueKT> <clueType>expression</clueType> <linkTheme>of</linkTheme> AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are known to be involved in the regulation of IL-2 gene promoter activity.</clue>
</event>
<event KT="Other" id="E19">
<type class="Regulation"/>
<theme idref="T27"/>
<clue>We analyzed expression of AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are known to be involved in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> IL-2 gene promoter activity.</clue>
</event>
<event KT="Fact" id="E20">
<type class="Correlation"/>
<theme idref="E19"/>
<theme idref="E15"/>
<clue>We analyzed expression of AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are <clueKT>known</clueKT> to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the regulation of IL-2 gene promoter activity.</clue>
</event>
<event KT="Fact" id="E21">
<type class="Correlation"/>
<theme idref="E19"/>
<theme idref="E16"/>
<clue>We analyzed expression of AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are <clueKT>known</clueKT> to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the regulation of IL-2 gene promoter activity.</clue>
</event>
<event KT="Fact" id="E22">
<type class="Correlation"/>
<theme idref="E19"/>
<theme idref="E17"/>
<clue>We analyzed expression of AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are <clueKT>known</clueKT> to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the regulation of IL-2 gene promoter activity.</clue>
</event>
<event KT="Fact" id="E23">
<type class="Correlation"/>
<theme idref="E19"/>
<theme idref="E18"/>
<clue>We analyzed expression of AP-1, NF-kappa B, NF-AT, and octamer binding transcription factors, which are <clueKT>known</clueKT> to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the regulation of IL-2 gene promoter activity.</clue>
</event>
<sentence id="S8">Large amounts of <term id="T29" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T30" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> and significant quantities of <term id="T31" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term> were induced in <term id="T32" lex="SEA-activated_CD4+_spleen_T_cell" sem="Cell_cultured"><term id="T33" lex="SEA" sem="Protein_molecule">SEA</term>-activated <term id="A6" sem="Cell_natural">CD4+ spleen T cells</term></term>, whereas <term id="A7" sem="Protein_molecule">Oct-1</term> and <term id="A8" sem="Protein_molecule">Oct-2</term> <term id="A9" sem="DNA_molecule">DNA</term> binding activity was similar in both resting and <term id="T35" lex="activated_T_cell" sem="Cell_natural">activated T cells</term>.</sentence>
<event id="E24">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="T33"/>
<clue>Large amounts of AP-1 and NF-kappa B and significant quantities of NF-AT were induced in SEA-<clueType>activated</clueType> CD4+ spleen T cells, whereas Oct-1 and Oct-2 DNA binding activity was similar in both resting and activated T cells.</clue>
</event>
<event Manner="High" id="E25">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue><clueManner>Large amounts</clueManner> of AP-1 and NF-kappa B and significant quantities of NF-AT were <clueType>induced</clueType> <clueLoc>in SEA-activated CD4+ spleen T cells</clueLoc>, whereas Oct-1 and Oct-2 DNA binding activity was similar in both resting and activated T cells.</clue>
</event>
<event Manner="High" id="E26">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<clue><clueManner>Large amounts</clueManner> of AP-1 and NF-kappa B and significant quantities of NF-AT were <clueType>induced</clueType> <clueLoc>in SEA-activated CD4+ spleen T cells</clueLoc>, whereas Oct-1 and Oct-2 DNA binding activity was similar in both resting and activated T cells.</clue>
</event>
<event Manner="High" id="E27">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<clue>Large amounts of AP-1 and NF-kappa B and <clueManner>significant quantities</clueManner> of NF-AT were <clueType>induced</clueType> <clueLoc>in SEA-activated CD4+ spleen T cells</clueLoc>, whereas Oct-1 and Oct-2 DNA binding activity was similar in both resting and activated T cells.</clue>
</event>
<event id="E28">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="A9"/>
<clue>Large amounts of AP-1 and NF-kappa B and significant quantities of NF-AT were induced in SEA-activated CD4+ spleen T cells, whereas Oct-1 and Oct-2 DNA <clueType>binding activity</clueType> was similar in both resting and activated T cells.</clue>
<comment>NER: T34 DEL</comment></event>
<event id="E300">
<type class="Binding"/>
<theme idref="A8"/>
<theme idref="A9"/>
<clue>Large amounts of AP-1 and NF-kappa B and significant quantities of NF-AT were induced in SEA-activated CD4+ spleen T cells, whereas Oct-1 and Oct-2 DNA <clueType>binding activity</clueType> was similar <clueLoc>in</clueLoc> both <clueLoc>resting</clueLoc> and activated <clueLoc>T cells</clueLoc>.</clue>
</event>
<event id="E301">
<type class="Binding"/>
<theme idref="A8"/>
<theme idref="A9"/>
<clue>Large amounts of AP-1 and NF-kappa B and significant quantities of NF-AT were induced in SEA-activated CD4+ spleen T cells, whereas Oct-1 and Oct-2 DNA <clueType>binding activity</clueType> was similar <clueLoc>in</clueLoc> both resting and <clueLoc>activated T cells</clueLoc>.</clue>
</event>
<sentence id="S9">In contrast, <term id="T36" lex="anergic_CD4+_T_cell" sem="Cell_natural">anergic CD4+ T cells</term> contained severely reduced levels of <term id="T37" lex="AP-1" sem="Protein_molecule">AP-1</term> and <term id="T38" lex="Fos/Jun-containing_NF-AT_complex" sem="Protein_complex">Fos/Jun-containing <term id="T39" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term> complexes</term> but expressed significant amounts of <term id="T40" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> and <term id="T41" lex="Oct_binding_protein" sem="Protein_family_or_group">Oct binding proteins</term> after <term id="T42" lex="SEA_stimulation" sem="Other"><term id="T43" lex="SEA" sem="Protein_molecule">SEA</term> stimulation</term>.</sentence>
<event id="E62">
<type class="Physiological_process"/>
<theme idref="T36"/>
<cause idref="T43"/>
<clue>In contrast, anergic CD4+ T cells contained severely reduced levels of AP-1 and Fos/Jun-containing NF-AT complexes but expressed significant amounts of NF-kappa B and Oct binding proteins after SEA <clueType>stimulation</clueType>.</clue>
</event>
<event Manner="High" id="E33">
<type class="Negative_regulation"/>
<theme idref="T37"/>
<cause idref="E62"/>
<clue>In contrast, anergic CD4+ T cells contained <clueManner>severely</clueManner> <clueType>reduced</clueType> levels of AP-1 and Fos/Jun-containing NF-AT complexes but expressed significant amounts of NF-kappa B and Oct binding proteins <linkCause>after</linkCause> SEA stimulation.</clue>
</event>
<event Manner="High" id="E34">
<type class="Negative_regulation"/>
<theme idref="T38"/>
<cause idref="E62"/>
<clue>In contrast, anergic CD4+ T cells contained <clueManner>severely</clueManner> <clueType>reduced</clueType> levels of AP-1 and Fos/Jun-containing NF-AT complexes but expressed significant amounts of NF-kappa B and Oct binding proteins <linkCause>after</linkCause> SEA stimulation.</clue>
</event>
<event Manner="High" id="E35">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>In contrast, anergic CD4+ T cells contained severely reduced levels of AP-1 and Fos/Jun-containing NF-AT complexes but <clueType>expressed</clueType> <clueManner>significant amounts</clueManner> of NF-kappa B and Oct binding proteins after SEA stimulation.</clue>
</event>
<event Manner="High" id="E50">
<type class="Gene_expression"/>
<theme idref="T41"/>
<clue>In contrast, anergic CD4+ T cells contained severely reduced levels of AP-1 and Fos/Jun-containing NF-AT complexes but <clueType>expressed</clueType> <clueManner>significant amounts</clueManner> of NF-kappa B and Oct binding proteins after SEA stimulation.</clue>
</event>
<event id="E51">
<type class="Positive_regulation"/>
<theme idref="E35"/>
<cause idref="E62"/>
<clue>In contrast, anergic CD4+ T cells contained severely reduced levels of AP-1 and Fos/Jun-containing NF-AT complexes but expressed significant amounts of NF-kappa B and Oct binding proteins <linkCause>after</linkCause> SEA stimulation.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E50"/>
<cause idref="E62"/>
<clue>In contrast, anergic CD4+ T cells contained severely reduced levels of AP-1 and Fos/Jun-containing NF-AT complexes but expressed significant amounts of NF-kappa B and Oct binding proteins <linkCause>after</linkCause> SEA stimulation.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S10">Resolution of the <term id="T44" lex="NF-kappa_B_complex" sem="Protein_complex"><term id="T45" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> complex</term> demonstrated predominant expression of <term id="T46" lex="p50-p65_heterodimer" sem="Protein_complex">p50-p65 heterodimers</term> in <term id="T47" lex="activated_CD4+_T_cell" sem="Cell_natural">activated <term id="A24" sem="Cell_natural">CD4+ T cells</term></term>, while anergic cells mainly expressed the transcriptionally inactive <term id="T48" lex="p50_homodimer" sem="Protein_molecule">p50 homodimer</term>.</sentence>
<event id="E37">
<type class="Gene_expression"/>
<theme idref="T46"/>
<clue>Resolution of the NF-kappa B complex demonstrated predominant <clueType>expression</clueType> <linkTheme>of</linkTheme> p50-p65 heterodimers <clueLoc>in activated CD4+ T cells</clueLoc>, while anergic cells mainly expressed the transcriptionally inactive p50 homodimer.</clue>
</event>
<event id="E38">
<type class="Gene_expression"/>
<theme idref="T48"/>
<clue>Resolution of the NF-kappa B complex demonstrated predominant expression of p50-p65 heterodimers in activated CD4+ T cells, while <clueLoc>anergic cells</clueLoc> mainly <clueType>expressed</clueType> the transcriptionally inactive p50 homodimer.</clue>
</event>
<event id="E63">
<type class="Physiological_process"/>
<theme idref="A24"/>
<clue>Resolution of the NF-kappa B complex demonstrated predominant expression of p50-p65 heterodimers in <clueType>activated</clueType> CD4+ T cells, while anergic cells mainly expressed the transcriptionally inactive p50 homodimer.</clue>
</event>
<sentence id="S11">These alterations of <term id="T49" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> are likely to be responsible for repression of <term id="T50" lex="IL-2" sem="Protein_molecule">IL-2</term> in <term id="T51" lex="anergic_T_cell" sem="Cell_natural">anergic T cells</term>.</sentence>
<event CL="L2" KT="Analysis" id="E39" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T50"/>
<cause idref="E38"/>
<clue><corefCause>These alterations of transcription factors</corefCause> are <clueKT><clueCL>likely</clueCL></clueKT> to be responsible for <clueType>repression</clueType> <linkTheme>of</linkTheme> IL-2 <clueLoc>in anergic T cells.</clueLoc></clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
